The abstract is read at the publisher; the summary is JClub's.
A152T carriers show distinct, cell type-specific transcriptional changes in excitatory neurons, oligodendrocytes, and astrocytes in both AD and PSP, despite similar cell type composition.
- Why it matters: The work addresses how the rare MAPT A152T risk variant contributes to tauopathy, and whether genetic risk can be detected in human brain cell expression patterns.
- What they did: Using single-nucleus RNA sequencing on postmortem brain tissue from A152T carriers and pathology-matched non-carriers with AD or PSP plus age-matched controls, the study performed differential expression and donor-level pseudo-bulk validation.
- The result: A152T-specific changes were strongest in excitatory neurons, oligodendrocytes, and astrocytes, and combining sporadic and A152T cases masked differences in multiple cell types, supporting genetic screening in snRNA-seq cohorts.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.